Human PD-L1 inhibitor V – 1 mg

Overview

The Human PD-L1 Inhibitor V is a highly specialized peptide designed to target the programmed cell death 1 (PD-1) receptor and its ligand PD-L1. These components play a critical role in modulating T cell activation, ensuring that immune responses are finely tuned to prevent excessive activity that could lead to autoimmune disorders or tumor growth. Unfortunately, many cancer cells exploit this pathway, overexpressing PD-L1 to evade immune detection. The Human PD-L1 Inhibitor V effectively binds to human PD-1, blocking the PD-1/PD-L1 interaction and helping to restore T cell activity against tumors.

Key Features

• Specifically inhibits the PD-1/PD-L1 binding, enhancing immunotherapeutic strategies.
• Contains key anchor residues (LDYVNRRKMYQ) critical for effective binding.
• Available in a 1 mg format, ideal for research applications.
• Developed for both in vitro and potential therapeutic use.
• Part of a broader range of high-quality peptides available in our catalog.

Specifications

FAQ

What is the mechanism of action of Human PD-L1 Inhibitor V?

This inhibitor works by binding to the PD-1 receptor, thus preventing PD-L1 from binding and inhibiting T cell activation, which is crucial for maintaining immune responses against tumors.

How should I store Human PD-L1 Inhibitor V?

It is recommended to store this peptide at -20°C to maintain its stability and integrity. Repeated freeze-thaw cycles should be avoided.

Can this peptide be used in vivo?

While Human PD-L1 Inhibitor V has shown potential for therapeutic applications, its use in vivo should be carefully evaluated in the context of specific research models and clinical trials.

Explore more peptides like PKG Substrate or Autocamtide-2 from our extensive selection to support your research needs.

Related Products

• CREBtide [KRREILSRRPSYR], 5-FAM labeled

Browse more in Peptides.